J. Blaser

2.0k citations

51 papers · 1.6k indexed · 1 hit paper · h-index 21

Impact in

Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
Applied Microbiology and Biotechnology top 1%
- Antibiotic Use and Resistance

Papers in ⓘ

Pharmacology 28
- Antibiotics Pharmacokinetics and Efficacy 28
Molecular Medicine 17
- Antibiotic Resistance in Bacteria 17

Co-authors: Stephen H. Zinner (10 shared papers)R Lüthy (11 shared papers)Christiane König (4 shared papers)Hans‐Peter Simmen (4 shared papers)Milos Opravil (3 shared papers)W. Zimmerli (1 shared paper)Pietro Giovanoli (2 shared papers)Andreas F. Widmer (1 shared paper)
Journals: Journal of Antimicrobial Chemotherapy (10 papers)Antimicrobial Agents and Chemotherapy (10 papers)Infection (3 papers)The Journal of Infectious Diseases (3 papers)European Journal of Clinical Microbiology & Infectious Diseases (2 papers)
Partner nations: Switzerland United States United Kingdom

In The Last Decade

J. Blaser

50 papers receiving 1.5k citations

Hit Papers

align trajectories log scale

Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance 1987 · 397 citations

Peers

Countries citing papers authored by J. Blaser

Since Specialization

Citations

This map shows the geographic impact of J. Blaser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Blaser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Blaser more than expected).

Fields of papers citing papers by J. Blaser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Blaser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Blaser. The network helps show where J. Blaser may publish in the future.

Co-authors

The 25 scholars most cited alongside J. Blaser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J. Blaser Line = papers co-authored together J. Blaser links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance Antimicrobial Agents and Chemotherapy ·J. Blaser, Benjamin B. Stone, Moritz Gröner, Stephen H. Zinner Hit paper breakdown →	1987	397
2	In-vitro model for simultaneous simulation of the serum kinetics of two drugs with different half-lives Journal of Antimicrobial Chemotherapy ·J. Blaser	1985	139
3	Two compartment kinetic model with multiple artificial capillary units Journal of Antimicrobial Chemotherapy ·J. Blaser, B. B. Stone, Stephen H. Zinner	1985	96
4	In vivo verification of in vitro model of antibiotic treatment of device-related infection Antimicrobial Agents and Chemotherapy ·J. Blaser, Patrice Vergères, Andreas F. Widmer, W. Zimmerli	1995	85
5	Analysis of pH, pO2 and pCO2 in drainage fluid allows for rapid detection of infectious complications during the follow-up period after abdominal surgery Infection ·Hans‐Peter Simmen, H Battaglia, Pietro Giovanoli, J. Blaser	1994	84
6	Efficacy of intermittent versus continuous administration of netilmicin in a two-compartment in vitro model Antimicrobial Agents and Chemotherapy ·J. Blaser, Benjamin B. Stone, Stephen H. Zinner	1985	80
7	Poor antibody response after tetanus and pneumococcal vaccination in immunocompromised, HIV-infected patients Clinical & Experimental Immunology ·Milos Opravil, Walter Fierz, L Matter, J. Blaser, R Lüthy	1991	66
8	Once-daily dosing of aminoglycosides European Journal of Clinical Microbiology & Infectious Diseases ·J. Blaser, Christiane König	1995	60
9	Physician compliance with advanced electronic alerts for preventing venous thromboembolism among hospitalized medical patients Journal of Thrombosis and Haemostasis ·Nils Kucher, M. PUCK, J. Blaser, Guido Bucklar, Emmanuel Eschmann, T Lüscher	2009	40
10	Role of Amoxicillin Serum Levels for Successful Prophylaxis of Experimental Endocarditis Due to Tolerant Streptococci The Journal of Infectious Diseases ·Ursula Flückiger, P Francioli, J. Blaser, M. P. Glauser, Philippe Moreillon	1994	35
11	Combination Therapy with Ciprofloxacin plus Azlocillin against Pseudomonas aeruginosa: Effect of Simultaneous versus Staggered Administration in an In Vitro Model of Infection The Journal of Infectious Diseases ·Michael N. Dudley, J. Blaser, Deborah Gilbert, Kenneth H. Mayer, Stephen H. Zinner	1991	32
12	Side-effects due to the intravenous infusion of erythromycin lactobionate Infection ·R. Putzi, J. Blaser, R Lüthy, R. Wehrli, W Siegenthaler	1983	30
13	Amikacin, Ceftazidime, and Flucloxacillin against Suspended and Adherent Pseudomonas aeruginosa and Staphylococcus epidermidis in an In Vitro Model of Infection The Journal of Infectious Diseases ·Patrice Vergères, J. Blaser	1992	29
14	From chronic conditions to relevance in multimorbidity: a four-step study in family medicine Family Practice ·Alexandra N’Goran, J. Blaser, Anouk Déruaz‐Luyet, Nicolas Senn, Pascal Frey, Dagmar M. Haller, Ryan Tandjung, Andreas Zeller, Bernard Burnand, Lilli Herzig	2016	28
15	Simulation of amoxicillin pharmacokinetics in humans for the prevention of streptococcal endocarditis in rats Antimicrobial Agents and Chemotherapy ·Ursula Flückiger, Philippe Moreillon, J. Blaser, Marc Bickle, M. P. Glauser, P Francioli	1994	27
16	Significance of "extravascular" protein binding for antimicrobial pharmacodynamics in an in vitro capillary model of infection Antimicrobial Agents and Chemotherapy ·Michael N. Dudley, J. Blaser, David N. Gilbert, Stephen H. Zinner	1990	26
17	Effect of pathological changes of pH, pO2 and pCO2 on the activity of antimicrobial agents in vitro European Journal of Clinical Microbiology & Infectious Diseases ·Christiane König, Hans‐Peter Simmen, J. Blaser	1993	26
18	In Vitro Models for the Study of Antibiotic Activities Birkhäuser Basel eBooks ·J. Blaser, Stephen H. Zinner	1987	26
19	Monitoring of co-trimoxazole concentrations in serum during treatment of pneumocystis carinii pneumonia Antimicrobial Agents and Chemotherapy ·Béda Joos, J. Blaser, Milos Opravil, J. P. Chave, R Lüthy	1995	25
20	Impact of netilmicin regimens on the activities of ceftazidime-netilmicin combinations against Pseudomonas aeruginosa in an in vitro pharmacokinetic model Antimicrobial Agents and Chemotherapy ·J. Blaser, Benjamin B. Stone, Moritz Gröner, Stephen H. Zinner	1985	24

About J. Blaser

J. Blaser is a scholar working on Pharmacology, Molecular Medicine, Epidemiology, Infectious Diseases and Clinical Psychology, having authored 51 papers that have together received 1.6k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (28 papers), Antibiotic Resistance in Bacteria (17 papers), Pneumonia and Respiratory Infections (8 papers), Antimicrobial Resistance in Staphylococcus (6 papers), Bacterial Identification and Susceptibility Testing (4 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers), Electronic Health Records Systems (3 papers) and Antibiotic Use and Resistance (3 papers). The work is most often cited by research in Molecular Medicine (654 citations), Applied Microbiology and Biotechnology (154 citations), Pharmacology (995 citations), Clinical Biochemistry (271 citations) and Infectious Diseases (363 citations). J. Blaser has collaborated with scholars based in Switzerland, United States and United Kingdom. Frequent co-authors include Stephen H. Zinner, R Lüthy, Christiane König, Hans‐Peter Simmen, Milos Opravil, W. Zimmerli, Pietro Giovanoli, Andreas F. Widmer, W Siegenthaler and Michael N. Dudley. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Antimicrobial Agents and Chemotherapy, Infection, The Journal of Infectious Diseases and European Journal of Clinical Microbiology & Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact